Skip to main content
CivicGate

HR 10919
Introduced Re-checks Congress.gov for new actions and updates the bill's status, and fills in any sponsors, committees, or related bills that are missing. It does not re-pull sponsors/cosponsors/committees/related — those rarely change — and it skips all work if nothing has changed upstream, so it's cheap to click.

Safety Net Provider Drug Pricing Protection Act

To amend title III of the Public Health Service Act to ensure that certain safety net providers are not required to pay more than the 340B ceiling price for covered outpatient drugs at the time of purchase.

Introduced Oct 29, 2026

Latest action (Oct 29, 2026) Referred to the House Committee on Energy and Commerce.

Referred to
Energy and Commerce Committee
Policy area
Health
Issues
Healthcare

Summary
  • Adds a new paragraph (11) to Section 340B(a) of the Public Health Service Act on upfront discounted pricing for certain safety net providers.
  • Bars the Secretary from entering into a manufacturer agreement under which a safety net covered entity pays more than the applicable ceiling price for a covered outpatient drug at the point of purchase.
  • Defines "safety net covered entity" to include covered entities described in specified subparagraphs of paragraph (4), certain entities that receive direct State or local government funding, and sole community hospitals described in subparagraph (O).
  • Provides that the Act does not permit arrangements in which these entities pay above the ceiling price at purchase and are later reimbursed through a rebate, reimbursement, or other payment.
  • Takes effect on enactment, applies to drugs purchased on or after enactment, and applies to existing manufacturer agreements beginning on the date of enactment.

AI-generated plain-language summary of the bill text — neutral, and may be imperfect. See the full text below for the exact wording.

Sponsor (1)
13 cosponsors

Money behind the sponsor

Top reported contributors to Jack Bergman’s campaign committee (2024 cycle) — who funds the bill’s sponsor, not a claim about this bill. Data from FEC.

  • Employer not reported $67,004
  • ART MORAN BUICK GMC $33,350
  • MIT45 $31,800
  • THE RICH DAD COMPANY $13,200
  • ZURICH $12,900

Organizations whose employees gave the most — itemized individual contributions grouped by the donor’s reported employer (FEC Schedule A). Full finance for Jack Bergman → · Outside spending →

Actions (2)
  1. Oct 29, 2026 Referred to the House Committee on Energy and Commerce. · house
  2. Oct 29, 2026 Introduced in House

Full text

IN THE HOUSE OF REPRESENTATIVES

October 29, 2026

Mr. Bergman (for himself, Mr. Ruiz, Mr. Cleaver, Mr. Mann, Ms. Titus, Ms. Norton, Ms. Davids of Kansas, Ms. Balint, Mr. Golden of Maine, Mr. Moulton, Mr. Hernandez, Ms. Stansbury, Mr. Austin Scott of Georgia, and Mr. Newhouse) introduced the following bill; which was referred to the Committee on Energy and Commerce

A BILL

To amend title III of the Public Health Service Act to ensure that certain safety net providers are not required to pay more than the 340B ceiling price for covered outpatient drugs at the time of purchase.

Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

This Act may be cited as the “Safety Net Provider Drug Pricing Protection Act”.

SEC. 2. ENSURING UPFRONT 340B DISCOUNTED PRICING FOR CERTAIN SAFETY NET PROVIDERS.

(a) In General.—Section 340B(a) of the Public Health Service Act (42 U.S.C. 256b(a)) is amended by adding at the end the following new paragraph:

“(11) Upfront discounted pricing for certain safety net providers.—

“(A) In general.—The Secretary may not enter into an agreement with a manufacturer of covered outpatient drugs under paragraph (1) under which the amount required to be paid to the manufacturer for covered outpatient drugs by a safety net covered entity exceeds, at the point of purchase of such drug, the applicable ceiling price for such drug (as described in paragraph (1)).

“(B) Safety net covered entity.—For purposes of subparagraph (A), the term ‘safety net covered entity’ means a covered entity that—

“(i) is described in any of subparagraphs

(A), (D), (F), (G), (H), (I), (J), or (N) of paragraph (4);

“(ii) is an entity described in subparagraph (K) of such paragraph that receives funds directly from a State or unit of local government; or

“(iii) is a sole community hospital described in subparagraph (O) of such paragraph.”.

(b) Rule of Construction.—Nothing in this section, or the amendment made by this section, shall be construed to permit under paragraph (1) of section 340B(a) of the Public Health Service Act (42 U.S.C. 256b(a)) any arrangement under which a safety net covered entity (as defined in paragraph (11)(B) of such section) pays to the manufacturer of a covered outpatient drug an amount in excess of the applicable ceiling price for such drug (as described in such paragraph

(1)) at the time of purchase, with later reconciliation by rebate, reimbursement, or other payment.

(c) Effective Dates.—

(1) In general.—The amendments made by this section shall take effect on the date of the enactment of this section and shall apply to drugs purchased on or after the date of the enactment of this section.

(2) Application to existing agreements.—Beginning on the date of the enactment of this section, the amendments made by this section shall be taken into account in determining whether an agreement with a manufacturer of covered outpatient drugs meets the requirements of section 340B(a) of the Public Health Service Act (42 U.S.C. 256b(a)). <all>

Text versions (1)
  • Introduced in House · Oct 29, 2026

Only one text version is on file, so there’s no earlier version to compare against yet.

Comments

Comments

Loading comments…